Stocks and Investing
Stocks and Investing
Tue, May 21, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Ben Hendrix Maintained (CHE) at Buy with Decreased Target to $697 on, May 21st, 2024
Ben Hendrix of RBC Capital, Maintained "Chemed Corporation" (CHE) at Buy with Decreased Target from $712 to $697 on, May 21st, 2024.
Ben has made no other calls on CHE in the last 4 months.
There is 1 other peer that has a rating on CHE. Out of the 1 peers that are also analyzing CHE, 0 agree with Ben's Rating of Hold.
This is the rating of the analyst that currently disagrees with Ben
- Michael Wiederhorn of "Oppenheimer" Maintained at Buy with Increased Target to $650 on, Thursday, February 29th, 2024
Contributing Sources